Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Israel Gp Ltd. Orbimed currently holds 3,161,489 shares of Novus Therapeutics, Inc. (NVUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Israel Gp Ltd. Orbimed has been a net seller of NVUS stock. They have purchased $208.3K and sold $2.2M worth of shares.
Israel Gp Ltd. Orbimed's most recent insider trade was on Feb 27, 2023, when they purchased 348,000 shares at $0.25 per share.
Israel Gp Ltd. Orbimed serves as Executive at Novus Therapeutics, Inc. (NVUS). They have executed 10 insider transactions totaling $2.4M over their tenure at the company.
Israel Gp Ltd. Orbimed holds the position of Executive at Novus Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Israel Gp Ltd. Orbimed has shown a selling trading pattern, with $208.3K in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Israel Gp Ltd. Orbimed was on Feb 12, 2021, when they purchased $5.5M worth of ACET shares. This transaction involved 420,299 shares at $13.00 per share.
Israel Gp Ltd. Orbimed currently owns 3,161,489 shares of Novus Therapeutics, Inc. (NVUS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Israel Gp Ltd. Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Israel Gp Ltd. Orbimed has 10 Form 4 filings on record as an insider at Novus Therapeutics, Inc..
Set alerts for Israel Gp Ltd. Orbimed and 40,000+ other insiders.